共 50 条
[44]
Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
[J].
HEADACHE,
2020, 60
:93-93
[48]
Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study
[J].
The Journal of Headache and Pain,
2019, 20
[50]
Eighteen-month long-term analysis of the effectiveness, safety and tolerability of subcutaneous sumatriptan in acute migraine treatment
[J].
NERVENARZT,
1996, 67 (06)
:471-483